中文English
ISSN 1001-5256
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

自身免疫性胰腺炎累及左侧髂血管旁组织1例报告

杨鑫 李腊梅 朱琦 杨新乐 王昕睿 蔡艳俊 李婉玉

引用本文:
Citation:

自身免疫性胰腺炎累及左侧髂血管旁组织1例报告

DOI: 10.3969/j.issn.1001-5256.2022.12.026
基金项目: 

2017年吉林大学第一医院交叉学科创新项目 JDYYJC006

伦理学声明:本例报告已获得患者知情同意。
利益冲突声明:所有作者均声明不存在利益冲突。
作者贡献声明:杨鑫负责文献查询,文章思路形成及撰写;李腊梅、朱琦、杨新乐负责文献查询及数据收集分析;王昕睿、李婉玉负责提供文章选题;蔡艳俊提供文章修改意见;李婉玉负责拟定写作思路,课题设计及修改文章。
详细信息
    通信作者:

    李婉玉,liwanyu@mails.jlu.edu.cn

Autoimmune pancreatitis involving left iliac paravascular tissue: A case report

Research funding: 

2017 Interdisciplinary Innovation Project of the First Hospital of Jilin University JDYYJC006

More Information
  • 图  1  CT提示胰头占位性病变及盆底软组织影

    注:a,箭头所示为治疗前胰腺病变;b,箭头所示为治疗前软组织病变;c,箭头所示为激素治疗后胰腺病变;d,箭头所示为激素治疗后软组织病变。

    Figure  1.  CT showed space occupying lesion of pancreatic head and soft tissue shadow of pelvic floor

    图  2  PET/CT提示胰头区、左侧髂血管旁软组织增厚伴代谢增高

    注:a,箭头所示为胰头病变;b,箭头所示为软组织病变。

    Figure  2.  PET/CT showed soft tissue thickening in the pancreatic head area and left iliac paravascular area with increased metabolism

    图  3  患者肝功能及IgG4变化趋势图

    注:a,2021年11月22日;b,2021年11月30日;c,2021年12月9日;d,2022年1月8日;e,2022年2月15日。

    Figure  3.  Changing trend of liver function and IgG4 in patient

  • [1] MA J, LIU YL. Corticosteroid therapy for autoimmune pancreatitis[J]. J Clin Hepatol, 2018, 34(8): 1599-1603. DOI: 10.3969/j.issn.1001-5256.2018.08.002.

    马娟, 刘玉兰. 自身免疫性胰腺炎的激素治疗[J]. 临床肝胆病杂志, 2018, 34(8): 1599-1603. DOI: 10.3969/j.issn.1001-5256.2018.08.002.
    [2] MASAKI Y, DONG L, KUROSE N, et al. Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders[J]. Ann Rheum Dis, 2009, 68(8): 1310-1315. DOI: 10.1136/ard.2008.089169.
    [3] DESHPANDE V, ZEN Y, CHAN JK, et al. Consensus statement on the pathology of IgG4-related disease[J]. Mod Pathol, 2012, 25(9): 1181-1192. DOI: 10.1038/modpathol.2012.72.
    [4] KHOSROSHAHI A, WALLACE ZS, CROWE JL, et al. International consensus guidance statement on the management and treatment of IgG4-related disease[J]. Arthritis Rheumatol, 2015, 67(7): 1688-1699. DOI: 10.1002/art.39132.
    [5] STONE JH, KHOSROSHAHI A, DESHPANDE V, et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations[J]. Arthritis Rheum, 2012, 64(10): 3061-3067. DOI: 10.1002/art.34593.
    [6] LI W, CHEN Y, SUN Z P, et al. Clinicopathological characteristics of immunoglobulin G4-related sialadenitis[J]. Arthritis Res Ther, 2015, 17(1): 186. DOI: 10.1186/s13075-015-0698-y.
    [7] LIU Y, XUE M, WANG Z, et al. Salivary gland involvement disparities in clinical characteristics of IgG4-related disease: a retrospective study of 428 patients[J]. Rheumatology (Oxford), 2020, 59(3): 634-640. DOI: 10.1093/rheumatology/kez280.
    [8] Editorial board of Chinese Journal of pancreatic diseases. Chinese consus on autoimune pancreatitis (Draft 2012, Shanghai)[J]. Chin J Pancreatol, 2012, 12(6): 410-418. DOI: 10.3760/cma.j.issn.1674-1935.2012.06.017.

    《中华胰腺病杂志》编委会. 我国自身免疫性胰腺炎共识意见(草案2012, 上海)[J]. 中华胰腺病杂志, 2012, 12(6): 410-418. DOI: 10.3760/cma.j.issn.1674-1935.2012.06.017.
    [9] CAI O, TAN S. From pathogenesis, clinical manifestation, and diagnosis to treatment: an overview on autoimmune pancreatitis[J]. Gastroenterol Res Pract, 2017, 2017: 3246459. DOI: 10.1155/2017/3246459.
    [10] MARUYAMA M, WATANABE T, KANAI K, et al. International consensus diagnostic criteria for autoimmune pancreatitis and its Japanese amendment have improved diagnostic ability over existing criteria[J]. Gastroenterol Res Pract, 2013, 2013: 456965. DOI: 10.1155/2013/456965.
    [11] LUO Y, PAN Q, YANG H, et al. Fibroblast activation protein-targeted PET/CT with 68Ga-FAPI for imaging IgG4-related disease: Comparison to 18F-FDG PET/CT[J]. J Nucl Med, 2021, 62(2): 266-271. DOI: 10.2967/jnumed.120.244723.
    [12] SAHANI DV, KALVA SP, FARRELL J, et al. Autoimmune pancreatitis: imaging features[J]. Radiology, 2004, 233(2): 345-352. DOI: 10.1148/radiol.2332031436.
    [13] MIZUSHIMA I, KASASHIMA S, FUJINAGA Y, et al. IgG4-related periaortitis/periarteritis: An under-recognized condition that is potentially life-threatening[J]. Mod Rheumatol, 2019, 29(2): 240-250. DOI: 10.1080/14397595.2018.1546367.
    [14] ZHANG J, CHEN H, MA Y, et al. Characterizing IgG4-related disease with 18F-FDG PET/CT: a prospective cohort study[J]. Eur J Nucl Med Mol Imaging, 2014, 41(8): 1624-1634. DOI: 10.1007/s00259-014-2729-3.
    [15] VLACHOU PA, KHALILI K, JANG HJ, et al. IgG4-related sclerosing disease: autoimmune pancreatitis and extrapancreatic manifestations[J]. Radiographics, 2011, 31(5): 1379-1402. DOI: 10.1148/rg.315105735.
    [16] INOUE D, YOSHIDA K, YONEDA N, et al. IgG4-related disease: dataset of 235 consecutive patients[J]. Medicine (Baltimore), 2015, 94(15): e680. DOI: 10.1097/MD.0000000000000680.
    [17] PENG L, ZHANG P, LI J, et al. IgG4-related aortitis/periaortitis and periarteritis: a distinct spectrum of IgG4-related disease[J]. Arthritis Res Ther, 2020, 22(1): 103. DOI: 10.1186/s13075-020-02197-w.
    [18] PERUGINO CA, WALLACE ZS, MEYERSOHN N, et al. Large vessel involvement by IgG4-related disease[J]. Medicine (Baltimore), 2016, 95(28): e3344. DOI: 10.1097/MD.0000000000003344.
    [19] INOUE D, ZEN Y, ABO H, et al. Immunoglobulin G4-related periaortitis and periarteritis: CT findings in 17 patients[J]. Radiology, 2011, 261(2): 625-633. DOI: 10.1148/radiol.11102250.
    [20] KANNO A, NISHIMORI I, MASAMUNE A, et al. Nationwide epidemiological survey of autoimmune pancreatitis in Japan[J]. Pancreas, 2012, 41(6): 835-839. DOI: 10.1097/MPA.0b013e3182480c99.
    [21] VAGLIO A, SALVARANI C, BUZIO C. Retroperitoneal fibrosis[J]. The Lancet, 2006, 367(9506): 241-251. DOI: 10.1016/S0140-6736(06)68035-5.
    [22] LIN W, LU S, CHEN H, et al. Clinical characteristics of immunoglobulin G4-related disease: a prospective study of 118 Chinese patients[J]. Rheumatology (Oxford), 2015, 54(11): 1982-1990. DOI: 10.1093/rheumatology/kev203.
    [23] WANG K, WANG Z, ZENG Q, et al. Clinical characteristics of IgG4-related retroperitoneal fibrosis versus idiopathic retroperitoneal fibrosis[J]. PLoS One, 2021, 16(2): e0245601. DOI: 10.1371/journal.pone.0245601.
    [24] PERUGINO CA, WALLACE ZS, MEYERSOHN N, et al. Large vessel involvement by IgG4-related disease[J]. Medicine (Baltimore), 2016, 95(28): e3344. DOI: 10.1097/MD.0000000000003344.
  • 加载中
图(3)
计量
  • 文章访问数:  1078
  • HTML全文浏览量:  861
  • PDF下载量:  43
  • 被引次数: 0
出版历程
  • 收稿日期:  2022-03-31
  • 录用日期:  2022-05-07
  • 出版日期:  2022-12-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回